At least 60 million syringes and infusion pumps are in turmoil as the FDA investigates China-made plastic syringes that changed dimensions. On Nov. 30, the FDA warned healthcare workers to avoid ...

After the U.S. Food and Drug Administration announced an investigation into reports of leaks, breakages and other quality issues with China-made plastic syringes, New Jersey-based medical technology ...

FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it is looking into reports of leaks, breakages ...

FDA recently issued a safety communication informing consumers of potential device failures with plastic syringes manufactured in China. “We are concerned that certain syringes manufactured in China ...

Nearly six months after the FDA told healthcare workers to avoid plastic syringes made in China, the agency has placed import alerts on three China-based medical supply manufacturers. In late November ...

The U.S. Food and Drug Administration has issued a safety notice to consumers, health care providers and facilities that it is evaluating plastic syringes made in China for potential device failures.

FDA’s ongoing investigation into plastic syringes made in China and distributed in the United States has revealed “more widespread” quality issues than originally known, the agency said in an update ...

The FDA is advising U.S. healthcare providers and patients to stop using any plastic syringes in their inventories that were made in China, if possible, as it looks into a spate of quality complaints.

FDA reported on Nov. 30 that it is evaluating plastic medical syringes made in China for potential device failures, such as leakage and breakage. The agency said in a statement issued on Thursday that ...